Cellular Biomedicine Group Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2020 to a ratio of 4.1, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Cellular Biomedicine Group Inc in Sep 30 2020 quarter, has decreased to 89 days, compared to 91 days, in the Jun 30 2020 quarter.

If we take a look into Healthcare sector 12 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2020 from to 90.

What is Receivable Turnover Ratio?
What is Cellular Biomedicine Group Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CBMG Receivables Turnover Ratio	(Sep 30 2020) III. Quarter	(Jun 30 2020) II. Quarter	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter
Y / Y Receivable Change	-44.15 %	-32.15 %	-3.58 %	631.23 %	105.76 %
Y / Y Revenue Change	-87.66 %	-90.13 %	2393.28 %	1031.04 %	271.52 %
Receivable Turnover Ratio (TTM)	4.1	4.02	5.98	3.64	4.57
CBMG's Total Ranking	# 90	#	#	#	# 5
Accounts Receivable average collection period days	89	91	61	100	80
Seq. Receivable Change	10.39 %	17.88 %	-66.21 %	27 %	34.12 %
Seq. Revenue Change	-74.07 %	-89.86 %	322.6 %	11.08 %	-79.27 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 1
Healthcare Sector	# 13
Overall Market	# 90

Receivable Turnover Ratio Statistics
High	Average	Low
8125.12	400.51	-5.36
(Sep 30 2019)		(Jun 30 2015)

CBMG Company Profile • Back to CBMG Efficiency Comparisons • Compare CBMG Receivables Turnover Ratio to its Competitors

Financial Statements
Cellular Biomedicine Group Inc 's Accounts Receivable	$ 0 Millions	Visit CBMG's Balance sheet
Cellular Biomedicine Group Inc 's Sales TTM	$ 2 Millions	Visit CBMG's Income Statement
Sources of CBMG's Revenues		Visit CBMG's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CBMG's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CBMG's Growth Rates	CBMG's Roa	CBMG's Inventory Turnover Ratio	CBMG's Dividend Comparisons
CBMG's Profitability Ratios	CBMG's Roi	CBMG's Asset Turnover Ratio	CBMG's Dividend Growth
CBMG's Valuation Ratios	CBMG's Roe	CBMG's Financial Strength Ratios	CBMG's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2020, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2020	Receivable at quarter ending Sep 30 2020
Benitec Biopharma Inc	13.61	$ 0.262 Millions	$ 0.019 Millions
Musclepharm Corporation	13.17	$ 66.727 Millions	$ 5.067 Millions
Sqz Biotechnologies Company	12.94	$ 6.121 Millions	$ 0.473 Millions
Patterson Companies Inc	12.80	$ 5,541.621 Millions	$ 432.946 Millions
Alpha Pro Tech Ltd	12.66	$ 84.600 Millions	$ 6.682 Millions
Morphic Holding inc	12.57	$ 38.710 Millions	$ 3.080 Millions
Crispr Therapeutics Ag	12.20	$ 77.365 Millions	$ 6.340 Millions
Electrocore Inc	12.19	$ 3.243 Millions	$ 0.266 Millions
Sanara Medtech Inc	12.13	$ 17.118 Millions	$ 1.411 Millions
Lifeloc Technologies Inc	11.95	$ 6.981 Millions	$ 0.584 Millions
Teladoc Health Inc	11.95	$ 867.130 Millions	$ 72.593 Millions
Travere Therapeutics Inc	11.90	$ 194.026 Millions	$ 16.309 Millions
Prothena Corporation Public Limited Company	11.89	$ 0.749 Millions	$ 0.063 Millions
Integrated Biopharma Inc	11.59	$ 56.535 Millions	$ 4.878 Millions
Surmodics Inc	11.53	$ 94.864 Millions	$ 8.225 Millions
American Bio Medica Corporation	11.48	$ 4.249 Millions	$ 0.370 Millions
National Healthcare Corp	11.24	$ 1,022.272 Millions	$ 90.958 Millions
Harmony Biosciences Holdings inc	11.17	$ 45.609 Millions	$ 4.082 Millions
Dariohealth Corp	11.17	$ 7.294 Millions	$ 0.653 Millions
Protalix Biotherapeutics inc	11.13	$ 61.162 Millions	$ 5.496 Millions
Sunwin Stevia International Inc.	11.10	$ 23.513 Millions	$ 2.118 Millions
Insulet Corporation	11.10	$ 867.694 Millions	$ 78.200 Millions
Co diagnostics Inc	11.06	$ 47.516 Millions	$ 4.294 Millions
Dmk Pharmaceuticals Corporation	10.99	$ 14.998 Millions	$ 1.365 Millions
The Pennant Group Inc	10.84	$ 372.478 Millions	$ 34.364 Millions
Adamas Pharmaceuticals Inc	10.83	$ 69.799 Millions	$ 6.443 Millions
Intellia Therapeutics Inc	10.81	$ 62.335 Millions	$ 5.767 Millions
Scienture Holdings Inc	10.77	$ 16.824 Millions	$ 1.562 Millions
Capforce Inc	10.61	$ 3.683 Millions	$ 0.347 Millions
Allied Healthcare Products inc	10.53	$ 34.108 Millions	$ 3.239 Millions

Date modified: 2026-09-08T15:10:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.